Pacira to Sell iovera Business to Zimmer Biomet for Up to $140 Million
Pacira BioSciences is divesting its iovera business to bolster its balance sheet and focus on biopharmaceuticals. The strategic M&A deal provides immediate cash flow to pay down debt while streamlining operations for growth.
View filing at SEC.gov →